Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Jakafi. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Abacavir is combined with Ruxolitinib.
Level 2 evidence
Abemaciclib
The risk or severity of liver damage can be increased when Ruxolitinib is combined with Abemaciclib.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Abiraterone is combined with Ruxolitinib.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Ruxolitinib.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Ruxolitinib.
Level 2 evidence
Acebutolol
Ruxolitinib may increase the bradycardic activities of Acebutolol.
Level 2 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Aceclofenac is combined with Ruxolitinib.
Level 2 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Acetohydroxamic acid is combined with Ruxolitinib.
Level 2 evidence
Acetylsalicylic acid
The risk or severity of liver damage can be increased when Acetylsalicylic acid is combined with Ruxolitinib.
Level 2 evidence
Acitretin
The risk or severity of liver damage can be increased when Acitretin is combined with Ruxolitinib.
Level 2 evidence
Acoramidis
The serum concentration of Ruxolitinib can be increased when it is combined with Acoramidis.
Level 1 evidence
Acyclovir
The risk or severity of liver damage can be increased when Acyclovir is combined with Ruxolitinib.
Level 2 evidence
Enter your NPI to unlock 20 major interactions for Jakafi
Jakafi (Ruxolitinib) has 1323 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Jakafi (Ruxolitinib) has 374 major, 717 moderate, and 232 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Jakafi. Always confirm against the full prescribing information.